The Future of Ophthalmic Therapeutics

Our Mission

We have an eye on vision research to redefine noninvasive ocular therapeutics.  Our goal is to provide ophthalmology professionals greater freedom and treatment options to provide optimal care for their patients.  Our world renowned research team is focused on developing noninvasive therapeutics for sight threatening diseases of both the anterior and posterior sections of the eye addressing a potential wide range of ocular diseases requiring therapies with drug transport and controlled release challenges.

We are leaders in the understanding drug transport through biophysical pathways and we are focused on ophthalmology and drug development.   

Aciont works with top world renowned medical and patient care experts, drug development and regulatory professionals in the fields ophthalmology and eye research. 

Read up on our peer reviewed research studies sponsored in large part by the National Eye Institute of the NIH.